Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H J Parra

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
La Revue De Medecine Interne|May 1, 1991
[The mysteries of lipoprotein (a): a bridge between thrombosis and atheroma]E Hachulla, H J Parra
Sante (Montrouge, France)|December 9, 2000
[Study of the protein profile of the Adélé tribe of Togo]A C Tété-Bénissan, P Duriez, H J Parra
European Journal of Clinical Investigation|February 1, 1991
Plasma concentrations of apolipoprotein A-I containing particles in normolipidaemic young menG Luc, H J Parra, G Zylberberg, et al.
Pathologie-Biologie|November 1, 1987
[Multivariate analysis of biological markers of excessive consumption of alcohol. Value of lipoprotein parameters]H J Parra, P Puchois, C Demarquilly, et al.
Annales De Biologie Clinique|January 1, 1990
[Lipoprotein (a). An additional marker of atherosclerosis]H Mezdour, H J Parra, G Aguie-Aguie, et al.
Clinical Endocrinology|October 1, 1990
Decreased HDL cholesterol in subclinical hypothyroidism: the effect of L-thyroxine therapyP Caron, C Calazel, H J Parra, et al.
The British Journal of Nutrition|February 1, 1997
Postprandial lipaemia is associated with increased levels of apolipoprotein A-IV in the triacylglycerol-rich fraction and decreased levels in the denser plasma fractionsJ Dallongeville, P Lebel, H J Parra, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 15, 1987
Black-white differences in serum Lp(a) lipoprotein levelsH J Parra, I Luyéyé, C Bouramoué, et al.
Metabolism: Clinical and Experimental|March 1, 1990
Effect of pravastatin, an HMG CoA reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by their apolipoprotein compositionJ M Bard, H J Parra, P Douste-Blazy, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 6, 1998
Beneficial effect on serum apo AI, apo B and Lp AI levels of Ramadan fastingA Adlouni, N Ghalim, R Saïle, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
La Revue De Medecine Interne|May 1, 1991
[The mysteries of lipoprotein (a): a bridge between thrombosis and atheroma]E Hachulla, H J Parra
Sante (Montrouge, France)|December 9, 2000
[Study of the protein profile of the Adélé tribe of Togo]A C Tété-Bénissan, P Duriez, H J Parra
European Journal of Clinical Investigation|February 1, 1991
Plasma concentrations of apolipoprotein A-I containing particles in normolipidaemic young menG Luc, H J Parra, G Zylberberg, et al.
Pathologie-Biologie|November 1, 1987
[Multivariate analysis of biological markers of excessive consumption of alcohol. Value of lipoprotein parameters]H J Parra, P Puchois, C Demarquilly, et al.
Annales De Biologie Clinique|January 1, 1990
[Lipoprotein (a). An additional marker of atherosclerosis]H Mezdour, H J Parra, G Aguie-Aguie, et al.
Clinical Endocrinology|October 1, 1990
Decreased HDL cholesterol in subclinical hypothyroidism: the effect of L-thyroxine therapyP Caron, C Calazel, H J Parra, et al.
The British Journal of Nutrition|February 1, 1997
Postprandial lipaemia is associated with increased levels of apolipoprotein A-IV in the triacylglycerol-rich fraction and decreased levels in the denser plasma fractionsJ Dallongeville, P Lebel, H J Parra, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 15, 1987
Black-white differences in serum Lp(a) lipoprotein levelsH J Parra, I Luyéyé, C Bouramoué, et al.
Metabolism: Clinical and Experimental|March 1, 1990
Effect of pravastatin, an HMG CoA reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by their apolipoprotein compositionJ M Bard, H J Parra, P Douste-Blazy, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 6, 1998
Beneficial effect on serum apo AI, apo B and Lp AI levels of Ramadan fastingA Adlouni, N Ghalim, R Saïle, et al.
Pageof 5